Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
Authors
Keywords
-
Journal
MYCOSES
Volume 60, Issue 3, Pages 146-154
Publisher
Wiley
Online
2016-11-23
DOI
10.1111/myc.12585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
- (2016) Neil R. H. Stone et al. DRUGS
- Antifungal Agents
- (2016) Jeniel E. Nett et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
- (2015) Tihana Bicanic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014
- (2014) C. C. Blyth et al. INTERNAL MEDICINE JOURNAL
- Deoxycholate Amphotericin B and Nephrotoxicity in the Pediatric Setting
- (2014) David F. Bes et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2013) Sabine Mousset et al. ANNALS OF HEMATOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Nephrotoxicity of Different Formulations of Amphotericin B: Summarizing Evidence by Network Meta-analysis
- (2013) Andrea Messori et al. CLINICAL INFECTIOUS DISEASES
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (FungisomeTM) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India
- (2012) MP Jadhav et al. INDIAN JOURNAL OF CANCER
- Emerging opportunistic yeast infections
- (2011) Marisa H Miceli et al. LANCET INFECTIOUS DISEASES
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety
- (2010) Richard J. Hamill et al. CLINICAL INFECTIOUS DISEASES
- The value of amphotericin B in the treatment of invasive fungal infections
- (2010) Michael Klepser JOURNAL OF CRITICAL CARE
- Liposomal Amphotericin B
- (2009) Marit D. Moen et al. DRUGS
- Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC®: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry
- (2008) David L. Paterson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Amphotericin B Formulations and Drug Targeting
- (2007) J.J. Torrado et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started